Awardee OrganizationHENRY M. JACKSON FDN FOR THE ADV MIL/MED
Description
Abstract Text
Opportunistic viral infections are prevalent in patients with
acquired immune deficiency syndrome (AIDS). To investigate the
possibility that opportunistic infections in the herpesvirus group
might induce expression from the human T-lymphotropic virus
type III (HTLV-III) long-terminal repeats (LTR), we constructed
permanent cell lines (murine and simian), containing the HTLV-III
LTR directing the chloramphenicol acetyltransferase (CAT) gene.
Whereas in transient gene expression assays, the HTLV-III LTR
express CAT activity as high as the simian virus-40 (SV40) early
promoter, no CAT activity is observed after chromatin
integration in permanent cell lines. Superinfection of these latent
HTLV-III LTR containing lines with herpes viruses reactivated the
HTLV-III LTR as determined by S1 nuclease RNA analysis.
Whereas simian virus-40 (SV40) and adenovirus infection of the
latent HTLV-III LTR containing cell lines did not activate HTLV-
III LTR expression. Reactivation of latent HTLV-III LTR
transcription is also observed after 5 azacytidine, cycloheximide
and UV irradiation treatments. Run-on transcription in isolated
nuclei, suggests that the activation is on the transcriptional level.
Activation by herpes simplex virus type 1 (HSV-1) required viral
immediate early (IE) gene expression as determined by virus
infection in the presence of cycloheximide and with mutants
defective in viral gene expression. The long-term objective of the
research described in this proposal is to elucidate the
mechanism(s) by which the HTLV-III LTR could be activated on
the transcriptional level. The specific aims are to identify the
viral gene products responsible for latent HTLV-III LTR
transcription activation; to establish permanent cell lines in
human B and T-cells containing the HTLV-III LTR; to identify the
mechanism(s) of repression of the HTLV-III regulatory region and
to define the HTLV-III LTR DNA sequences involved repression
and reactivation. The preliminary results suggest that
opportunistic infection of the herpesvirus group could induce
HTLV-III expression in individuals harboring the virus in a latent
form and points to the potential of these cell lines to study the
affects of other physiochemical stimuli on HTLV-III reactivation.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
144676566
UEI
UYLKBRENAPG5
Project Start Date
30-September-1989
Project End Date
30-April-1993
Budget Start Date
01-September-1991
Budget End Date
30-April-1993
Project Funding Information for 1991
Total Funding
$83,996
Direct Costs
$72,410
Indirect Costs
$11,586
Year
Funding IC
FY Total Cost by IC
1991
National Institute of Allergy and Infectious Diseases
$83,996
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R29AI024489-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29AI024489-05
Patents
No Patents information available for 5R29AI024489-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29AI024489-05
Clinical Studies
No Clinical Studies information available for 5R29AI024489-05
News and More
Related News Releases
No news release information available for 5R29AI024489-05
History
No Historical information available for 5R29AI024489-05
Similar Projects
No Similar Projects information available for 5R29AI024489-05